Billy Joel, the renowned singer, has announced the cancellation of his future performances following a diagnosis of a neurological condition predominantly seen in individuals over 65 years old.
At 76, Joel has decided to cancel 17 shows scheduled for 2025 and 2026, including two in the UK, after medical professionals advised him against continuing live performances.
Known for iconic songs like ‘Piano Man’, ‘Uptown Girl’, and ‘We Didn’t Start the Fire’, this news will surely disappoint fans. However, it is crucial for Joel to prioritize his health and receive necessary treatment.
Diagnosed with Normal Pressure Hydrocephalus (NPH), Joel joins approximately 0.2 percent of people aged 70 to 80 affected by this condition, as reported by the Cleveland Clinic.
On Friday, May 23, Joel’s team released a statement on Instagram detailing his health situation.
The statement reads: “Billy Joel has announced that he will be cancelling all scheduled concerts following a recent diagnosis of Normal Pressure Hydrocephalus (NPH). This condition has been exacerbated by recent concert performances, leading to problems with hearing, vision, and balance.
“Under his doctor’s instructions, Billy is undergoing specific physical therapy and has been advised to refrain from performing during this recovery period.
“Billy is thankful for the excellent care he is receiving and is fully committed to prioritizing his health. He is grateful for the support from fans during this time and looks forward to the day when he can once again take the stage.”
He also expressed his regret, saying, “I’m sincerely sorry to disappoint our audience and thank you for understanding.”
The Cleveland Clinic explains that symptoms of NPH can include difficulty lifting feet, shortened and unsteady steps, and an uncertain walking pattern.
Other indicators include slowed mental and physical functions, memory issues, shifts in emotional behavior, and even erectile dysfunction.
The Cleveland Clinic also notes a possible link between NPH and brain diseases such as Alzheimer’s and dementia.
Their site states: “Researchers are continuing to explore exactly how and why NPH happens and whether or not other conditions can contribute to it. Answers to those questions could eventually help prevent or better treat this condition.”
Additionally, factors such as brain aneurysms, tumors, brain infections, or strokes may lead to the development of NPH.
Fortunately, NPH is highly treatable, often through surgery involving a device known as a shunt to alleviate symptoms.
Medication is seldom required in treating NPH.